Zidovudine Production Cost Reports

The report provides a detailed analysis essential for establishing a Zidovudine production plant. It encompasses all critical aspects necessary for Zidovudine production, including the cost of Zidovudine production, Zidovudine plant cost, Zidovudine production costs, and the overall Zidovudine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Zidovudine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Zidovudine (AZT) is an essential antiviral medication mainly used in the treatment of HIV infection. It is a nucleoside reverse transcriptase inhibitor (NRTI). It helps control HIV by inhibiting the replication of the virus, thereby reducing viral load and allowing the immune system to function more effectively. It is also important in preventing mother-to-child transmission of HIV during pregnancy and childbirth. Additionally, it can be administered as post-exposure prophylaxis after potential exposure to the virus.

The market demand for Zidovudine is majorly driven by its application as an antiviral medication to treat HIV infection, which elevates its demand in the medical and pharmaceutical industries. The global rise in the number of HIV cases boosts the demand for Zidovudine. Its utilization in combination with other antiretroviral medications as part of highly active antiretroviral therapy (HAART), fuels its market expansion. The increasing support from regulatory bodies for the treatments of HIV/AIDS facilitates quicker approvals and market access for Zidovudine and its combinations with other antiretroviral drugs. This support further promotes industrial Zidovudine procurement. Also, various global health initiatives aimed at combating HIV/AIDS increase awareness and access to treatment options, such as Zidovudine, which supports its market growth.

Raw Material for Zidovudine Production

According to the Zidovudine production plant project report, the various raw materials for Zidovudine production include 1-(2′-deoxy-5′-O-trityl-β-d-lyxosyl)thymine and methansulfonyl chloride.

Production Process of Zidovudine

The extensive Zidovudine production cost report consists of the following major industrial production process:

• Production from chemical synthesis: The production process of Zidovudine initiates with the treatment of 1-(2′-deoxy-5′-O-trityl-β-d-lyxosyl)thymine with methansulfonyl chloride in pyridine to form the corresponding mesylate. The methyl group in the compound is replaced with an azide group using lithium azide in dimethylformamide to give the product with the inverted configuration at C3 of the furanose ring. The product is heated in 80% acetic acid to remove the trityl protection. This reaction finally produces Zidovudine as the final product.

Properties of Zidovudine

Zidovudine (AZT) is a synthetic nucleoside analog of thymidine. It is a white to off-white crystal or needle having the molecular formula C10H13N5O4C10H13N5O4 and a molecular weight of 267.25 g/mol. It has a melting point in the range of 106-115 degrees Celsius, which depends on the solvent used for crystallization. It is soluble in water (25 mg/mL at 25 degrees Celsius) and ethanol (67 mg/mL). It has a pKa of 9.68, which indicates its weakly basic nature. It has an optical rotation of +99° (c = 0.5 in water) and has a density of 1.3382 g/cm³. It is sensitive to light and hygroscopic, which necessitates careful storage conditions between 2-8 degrees Celsius. Its stability allows it to remain effective for two years when stored properly, although solutions in DMSO or ethanol should be kept at -20 degrees Celsius for up to three months.